Search results for: Health Policy and Regulation
Filter search results
Reflections from the Region: Healthcare transformation in the Middle East
18 June 2025
…This is a space where our long-standing work on productivity, skill mix, and safe staffing resonates—and where we’re seeing real appetite for evidence-informed policy design. Drug pricing and access, too,…
New Drugs to Tackle Antimicrobial Resistance: Analysis of EU Policy Options
1 April 2011
…global public health threat, AMR reduces the chances of successfully treating patients with infectious diseases, thereby increasing the probability of complications, morbidity and mortality. The World Health Organization estimates that…
Franz Pichler
10 April 2026
Franz Pichler, PhD, is Principal and Founder of Confluence Health Consulting, a firm that specializes in pharmaceutical external affairs. Franz received his PhD in Genetics from the University of Auckland…
Neil Grubert
12 January 2026
…and writer. He is a leading voice on pharmaceutical pricing and market access, with more than 28,000 followers of his daily posts for insights into global trends and policy developments….
Salah Ghabri
12 March 2026
…interventions, economic modelling, uncertainty and sharing risk/pricing analysis, and HTA methods. He is member of different ISPOR and HTAi tasks force and member of editorial boards of health economic journals….
Claire Green
22 May 2014
Claire Green has been working for OHE now for 15 years. She originally joined OHE as she was (and still is) passionate about decision-makers making the best decisions for their…
Helen Hayes
2 June 2023
…and supply side factors of health: payment systems, waiting times, healthcare utilisation, the working lives of GPs, and links between labour market outcomes and health. Her recent research interests have…
Kelsey Moore
17 March 2025
…managed complex client engagements, facilitated stakeholder engagement processes, and coordinated public health initiatives addressing the opioid epidemic and mental health. Additionally, she has worked as a research assistant in the…
Benefiting from the Promise of Personalised Medicine: Recent OHE Presentations
18 February 2014
…situation in England, including the context and current status of pricing and reimbursement decisions, issues that are peculiar to England’s approach, and others that are common across countries, including those…